22-hydroxycholesterol has been researched along with resiquimod in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asgarova, A; Biichlé, S; Ceroi, A; Delettre, FA; Duperrier, A; Gauthier, T; Lagrost, L; Marotel, C; Masson, D; Mourey, G; Perruche, S; Saas, P | 1 |
1 other study(ies) available for 22-hydroxycholesterol and resiquimod
Article | Year |
---|---|
The anti-inflammatory effects of platelet-derived microparticles in human plasmacytoid dendritic cells involve liver X receptor activation.
Topics: Angiogenic Proteins; ATP Binding Cassette Transporter 1; Benzoates; Benzylamines; Blood Platelets; Cell-Derived Microparticles; Dendritic Cells; Endothelial Cells; Gene Expression Regulation; Humans; Hydrocarbons, Fluorinated; Hydroxycholesterols; Imidazoles; Immunity, Innate; Liver X Receptors; NF-kappa B; Oligodeoxyribonucleotides; Phenylenediamines; Primary Cell Culture; Receptors, G-Protein-Coupled; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Sulfonamides; Toll-Like Receptor 7; Tumor Necrosis Factor-alpha | 2016 |